gene	event	source	sourceEvent	sourceUrls	treatment	applicableCancerType	applicableDoid	blacklistCancerTypes	level	direction	evidenceUrls
ALK	FUSION	VICC_CGI	fusion	http	Crizotinib	Lung Adenocarcinoma	X		A	RESPONSIVE	https
BRCA1	INACTIVATION	VICC_CGI	inac	http	DRUP	Solid Tumors	X	Hematologic cancer,2531	B	RESPONSIVE	http
ERBB2	AMPLIFICATION	VICC_CGI	amp	http	Trastuzumab	Breast Cancer	X		A	RESPONSIVE	http
ERBB2	AMPLIFICATION	VICC_CGI	amp	http	Panitumumab	Colorectal Cancer	X		B	RESISTANT	http
FGFR2	FUSION	VICC_CGI	fusion	http	Erdafitinib	Bladder Cancer	X		B	RESPONSIVE
MET	AMPLIFICATION	VICC_CGI	amp	http	DRUP	Advanced Solid Tumor	X	Hematologic cancer,2531	B	RESPONSIVE
NRAS	ACTIVATION	VICC_CGI	act	http	Cetuximab	Colorectal Cancer	X		A	RESISTANT	http